Innovation in Community Oncology: Moving Faster, Close to Home

Why It Matters

These developments enable patients to receive cutting‑edge cancer care closer to home while positioning community oncology as a hub for clinical research and value‑based reimbursement.

Key Takeaways

• Community practices are adopting CAR‑T and bispecific antibody therapies
• AI tools reduce documentation, freeing clinicians for patient care
• Flatiron’s VALID Framework standardizes real‑world oncology data quality
• Advocacy tackles reimbursement and prior‑authorization barriers in community oncology

Pulse Analysis

The convergence of artificial intelligence, real‑world evidence, and regulatory reform is reshaping community oncology. Platforms like Flatiron’s VALID Framework provide a peer‑reviewed method to assess data extracted by large language models, ensuring that insights from everyday practice meet rigorous scientific standards. Paradigm Health’s acquisition of Flatiron’s clinical research business creates a network spanning nearly 100 community sites, accelerating the flow of trial data and enabling real‑time trial enrollment. This ecosystem lowers the barrier for community clinics to contribute to drug development and to adopt next‑generation therapies.

Delivering complex treatments such as CAR‑T and bispecific antibodies outside academic centers demands substantial infrastructure upgrades. Practices must expand infusion suites, implement robust emergency protocols, and integrate pharmacy leadership to manage high‑cost agents. Simultaneously, payer alignment is essential; without clear reimbursement pathways, the financial risk of offering these therapies can be prohibitive. AI-driven operational tools, including ambient documentation assistants, help offset staffing pressures by reclaiming clinician time, allowing teams to focus on patient care and complex decision‑making.

Advocacy and peer collaboration are the final pillars of sustainable innovation. Federal policy discussions at the conference underscored the urgency of addressing step therapy, copay assistance, and prior‑authorization hurdles that threaten access. By sharing best practices and building relationships across the community oncology landscape, practices can collectively negotiate better terms with payers and influence policy. The combined push for technological adoption, financial viability, and coordinated advocacy promises to keep advanced cancer care within reach for patients nationwide.